PLA2G4B Antikörper
Kurzübersicht für PLA2G4B Antikörper (ABIN7243199)
Target
Alle PLA2G4B Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Produktmerkmale
- Polyclonal Antibody
-
Aufreinigung
- Affinity purification
-
Immunogen
- Synthetic peptide of human PLA2G4B
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- WB 1:1000-1:5000
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.6 mg/mL
-
Buffer
- PBS with 0.05 % sodium azide and 50 % glycerol, PH7.4
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20°C. Avoid freeze / thaw cycles.
-
-
- PLA2G4B (Phospholipase A2, Group IVB (Cytosolic) (PLA2G4B))
-
Andere Bezeichnung
- PLA2G4B
-
Hintergrund
- This gene encodes a member of the cytosolic phospholipase A2 protein family. Phospholipase A2 enzymes hydrolyze the sn-2 bond of phospholipids, releasing lysophospholipids and fatty acids. This enzyme may be associated witHuman, Mouseitochondria and early endosomes. Most tissues also express read-through transcripts from the upstream gene into this gene, some of whicHuman, Mouseay encode fusion proteins combining the N-terminus of the upstream gene including its JmjC domain with the almost complete coding region of this gene, including the C2 and cytoplasmic phospholipase A2 domains.
-
Molekulargewicht
- 88 kDa
-
NCBI Accession
- NP_001108105
-
UniProt
- P0C869
-
Pathways
- ER-Nucleus Signaling, VEGF Signaling
Target
-